Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2034

Published Jul 09, 2025

Length 346 Pages

SKU # BRC20178140

Description

Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global induced pluripotent stem cells (iPSC) market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description:

Where is the largest and fastest-growing market for induced pluripotent stem cells (iPSC)? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The induced pluripotent stem cells (iPSC) market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider induced pluripotent stem cells (iPSC) market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by derived cell type, by application and by end-user.
Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
Global Market Size And Growth- Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by derived cell type, by application and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Recent Developments- Information on recent developments in the market covered in the report.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for induced pluripotent stem cells (iPSC) providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Derived Cell Type: Hepatocytes; Fibroblasts; Keratinocytes; Amniotic Cells; Other Derived Cell Types

2) By Application: Academic Research; Drug Discovery And Toxicity Studies; Regenerative Medicine; Cell And Gene Therapy

3) By End-User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Other End Users

Companies Mentioned: FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc); Thermo Fisher Scientific Inc.; STEMCELL Technologies Inc.; Lonza Group AG; Miltenyi Biotec GmbH

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; induced pluripotent stem cells (iPSC) indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1 Executive Summary: 1.1 Induced Pluripotent Stem Cell (iPSC) – Market Attractiveness And Macro Economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics: 6.1 General Market Definition; 6.2 Summary; 6.3 Induced Pluripotent Stem Cell (iPSC) Market Definition And Segmentations; 6.4 Market Segmentation By Derived Cell Type; 6.4.1 Hepatocytes; 6.4.2 Fibroblasts; 6.4.3 Keratinocytes; 6.4.4 Amniotic Cells; 6.4.5 Other Derived Cell Types; 6.5 Market Segmentation By Application; 6.5.1 Academic Research; 6.5.2 Drug Discovery And Toxicity Studies; 6.5.3 Regenerative Medicine; 6.5.4 Cell And Gene Therapy; 6.6 Market Segmentation By End-User; 6.6.1 Academic And Research Institutes; 6.6.2 Pharmaceutical And Biotechnology Companies; 6.6.3 Other End Users
7 Major Market Trends: 7.1 Ready-To-Use iPSC Cell Lines Pave Way For Off-The-Shelf Cell Therapies; 7.2 Innovative iPSC-Based Cancer Therapy Moves Forward With Significant Investment; 7.3 Standardized iPSC Lines Enhance Efficiency In Therapeutic Development; 7.4 Strategic Partnership Targets Commercialization Of Gene-Edited iPSCs; 7.5 Advancing CNS Drug Development With Human iPSC-Based BBB Models
8 Global Induced Pluripotent Stem Cell (iPSC) Growth Analysis And Strategic Analysis Framework: 8.1 Global: PESTEL Analysis; 8.1.1 Political; 8.1.2 Economic; 8.1.3 Social; 8.1.4 Technological; 8.1.5 Environmental; 8.1.6 Legal; 8.2 Analysis Of End Use Industries (B2B); 8.2.1 Pharmaceutical And Biotechnology Companies; 8.2.2 Academic And Research Institutes; 8.2.3 Other End Users; 8.3 Global Induced Pluripotent Stem Cell (iPSC) Market Growth Rate Analysis; 8.4 Historic Market Growth, 2019 – 2024, Value ($ Million); 8.4.1 Market Drivers 2019 – 2024; 8.4.2 Market Restraints 2019 – 2024; 8.5 Forecast Market Growth, 2024 – 2029, 2034F Value ($ Million); 8.6 Forecast Growth Contributors/Factors; 8.6.1 Quantitative Growth Contributors; 8.6.2 Drivers; 8.6.3 Restraints; 8.7 Global Induced Pluripotent Stem Cell (iPSC) Total Addressable Market (TAM)
9 Global Induced Pluripotent Stem Cell (iPSC) Market Segmentation: 9.1 Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.2 Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.3 Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.4 Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Hepatocytes, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.5 Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Fibroblasts, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.6 Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Keratinocytes, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.7 Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation By Amniotic Cells, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.8 Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation By Other Derived Cells, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10 Induced Pluripotent Stem Cell (iPSC) Market, Regional and Country Analysis: 10.1 Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 10.2 Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11 Asia-Pacific Market: 11.1 Summary; 11.2 Market Overview; 11.2.1 Region Information; 11.2.2 Market Information; 11.2.3 Background Information; 11.2.4 Government Initiatives; 11.2.5 Regulations; 11.2.6 Regulatory Bodies; 11.2.7 Major Associations; 11.2.8 Taxes Levied; 11.2.9 Corporate Tax Structure; 11.2.10 Investments; 11.2.11 Major Companies; 11.3 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.4 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.5 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.6 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis; 11.7 China Market; 11.8 Summary; 11.9 Market Overview; 11.9.1 Country Information; 11.9.2 Market Information; 11.9.3 Background Information; 11.9.4 Government Initiatives; 11.9.5 Regulations; 11.9.6 Regulatory Bodies; 11.9.7 Major Associations; 11.9.8 Taxes Levied; 11.9.9 Corporate Tax Structure; 11.9.10 Investments; 11.9.11 Major Companies; 11.10 China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.11 China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.12 China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.13 India Market; 11.14 India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.15 India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.16 India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.17 Japan Market; 11.18 Summary; 11.19 Market Overview; 11.19.1 Country Information; 11.19.2 Market Information; 11.19.3 Background Information; 11.19.4 Government Initiatives; 11.19.5 Regulations; 11.19.6 Regulatory Bodies; 11.19.7 Major Associations; 11.19.8 Taxes Levied; 11.19.9 Corporate Tax Structure; 11.19.10 Investments; 11.19.11 Major Companies; 11.20 Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.21 Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.22 Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.23 South Korea Market; 11.24 Summary; 11.25 Market Overview; 11.25.1 Country Information; 11.25.2 Market Information; 11.25.3 Background Information; 11.25.4 Government Initiatives; 11.25.5 Regulations; 11.25.6 Regulatory Bodies; 11.25.7 Major Associations; 11.25.8 Taxes Levied; 11.25.9 Corporate Tax Structure; 11.25.10 Investments; 11.25.11 Major Companies; 11.26 South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.27 South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.28 South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.29 Australia Market; 11.30 Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.31 Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.32 Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.33 Indonesia Market; 11.34 Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.35 Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.36 Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12 Western Europe Market: 12.1 Summary; 12.2 Market Overview; 12.2.1 Region Information; 12.2.2 Market Information; 12.2.3 Background Information; 12.2.4 Government Initiatives; 12.2.5 Regulations; 12.2.6 Regulatory Bodies; 12.2.7 Major Associations; 12.2.8 Taxes Levied; 12.2.9 Corporate tax structure; 12.2.10 Investments; 12.2.11 Major Companies; 12.3 Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.4 Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.5 Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.6 Western Europe Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis; 12.7 UK Market; 12.8 UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.9 UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.10 UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.11 Germany Market; 12.12 Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.13 Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.14 Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.15 France Market; 12.16 France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.17 France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.18 France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.19 Italy Market; 12.20 Italy Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.21 Italy Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.22 Italy Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.23 Spain Market; 12.24 Spain Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.25 Spain Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.26 Spain Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13 Eastern Europe Market: 13.1 Summary; 13.2 Market Overview; 13.2.1 Region Information; 13.2.2 Market Information; 13.2.3 Background Information; 13.2.4 Government Initiatives; 13.2.5 Regulations; 13.2.6 Regulatory Bodies; 13.2.7 Major Associations; 13.2.8 Taxes Levied; 13.2.9 Corporate Tax Structure; 13.2.10 Investments; 13.2.11 Major Companies; 13.3 Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.4 Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.5 Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.6 Russia Market; 13.7 Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.8 Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.9 Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14 North America Market: 14.1 Summary; 14.2 Market Overview; 14.2.1 Region Information; 14.2.2 Market Information; 14.2.3 Background Information; 14.2.4 Government Initiatives; 14.2.5 Regulations; 14.2.6 Regulatory Bodies; 14.2.7 Major Associations; 14.2.8 Taxes Levied; 14.2.9 Corporate Tax Structure; 14.2.10 Investments; 14.2.11 Major Companies; 14.3 North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.4 North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.5 North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.6 USA Market; 14.7 Summary; 14.8 Market Overview; 14.8.1 Country Information; 14.8.2 Market Information; 14.8.3 Background Information; 14.8.4 Government Initiatives; 14.8.5 Regulations; 14.8.6 Regulatory Bodies; 14.8.7 Major Associations; 14.8.8 Taxes Levied; 14.8.9 Corporate Tax Structure; 14.8.10 Investments; 14.8.11 Major Companies; 14.9 USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.10 USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.11 USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.12 Canada Market; 14.13 Summary; 14.14 Market Overview; 14.14.1 Country Information; 14.14.2 Market Information; 14.14.3 Background Information; 14.14.4 Government Initiatives; 14.14.5 Regulations; 14.14.6 Regulatory Bodies; 14.14.7 Major Associations; 14.14.8 Taxes Levied; 14.14.9 Corporate Tax Structure; 14.14.10 Investments; 14.14.11 Major Companies; 14.15 Canada Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.16 Canada Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.17 Canada Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15 South America Market: 15.1 Summary; 15.2 Market Overview; 15.2.1 Region Information; 15.2.2 Market Information; 15.2.3 Background Information; 15.2.4 Government Initiatives; 15.2.5 Regulations; 15.2.6 Regulatory Bodies; 15.2.7 Major Associations; 15.2.8 Taxes Levied; 15.2.9 Corporate Tax Structure; 15.2.10 Investments; 15.2.11 Major Companies; 15.3 South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.4 South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.5 South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.6 Brazil Market; 15.7 Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.8 Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.9 Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16 Middle East Market: 16.1 Summary; 16.2 Market Overview; 16.2.1 Region Information; 16.2.2 Market Information; 16.2.3 Background Information; 16.2.4 Government Initiatives; 16.2.5 Regulations; 16.2.6 Regulatory Bodies; 16.2.7 Major Associations; 16.2.8 Taxes Levied; 16.2.9 Corporate Tax Structure; 16.2.10 Investments; 16.2.11 Major Companies; 16.3 Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 16.4 Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 16.5 Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
17 Africa Market: 17.1 Summary; 17.2 Market Overview; 17.2.1 Region Information; 17.2.2 Market Information; 17.2.3 Background Information; 17.2.4 Government Initiatives; 17.2.5 Regulations; 17.2.6 Regulatory Bodies; 17.2.7 Major Associations; 17.2.8 Taxes Levied; 17.2.9 Corporate Tax Structure; 17.2.10 Major Companies; 17.3 Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 17.4 Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 17.5 Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
18 Competitive Landscape And Company Profiles: 18.1 Company Profiles; 18.2 FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc).; 18.2.1 Company Overview; 18.2.2 Products And Services; 18.2.3 Business Strategy; 18.2.4 Financial Overview; 18.3 Thermo Fisher Scientific Inc.; 18.3.1 Company Overview; 18.3.2 Products And Services; 18.3.3 Business Strategy; 18.3.4 Financial Overview; 18.4 STEMCELL Technologies Inc.; 18.4.1 Company Overview; 18.4.2 Products And Services; 18.4.3 Business Strategy; 18.4.4 Financial Overview; 18.5 Lonza Group AG; 18.5.1 Company Overview; 18.5.2 Products And Services; 18.5.3 Financial Overview; 18.6 Miltenyi Biotec GmbH; 18.6.1 Company Overview; 18.6.2 Products And Services; 18.6.3 Financial Overview
19 Other Major Companies: 19.1 Takara Bio Inc.; 19.1.1 Company Overview; 19.1.2 Products And Services; 19.2 Astellas Pharma Inc.; 19.2.1 Company Overview; 19.2.2 Products And Services; 19.3 Fate Therapeutics Inc.; 19.3.1 Company Overview; 19.3.2 Products And Services; 19.4 ViaCyte Inc.; 19.4.1 Company Overview; 19.4.2 Products And Services; 19.5 Sartorius; 19.5.1 Company Overview; 19.5.2 Products And Services; 19.6 Shanghai Cell Therapy Group Ltd.; 19.6.1 Company Overview; 19.6.2 Products And Services; 19.7 Ncardia; 19.7.1 Company Overview; 19.7.2 Products And Services; 19.8 REPROCELL USA Inc.; 19.8.1 Company Overview; 19.8.2 Products And Services; 19.9 Applied StemCells Inc.; 19.9.1 Company Overview; 19.9.2 Products And Services; 19.10 Treefrog Therapeutics Inc.; 19.10.1 Company Overview; 19.10.2 Products And Services; 19.11 Japan Tissue Engineering Co. Ltd.; 19.11.1 Company Overview; 19.11.2 Products And Services; 19.12 DefiniGEN; 19.12.1 Company Overview; 19.12.2 Products And Services; 19.13 Merck KGaA.; 19.13.1 Company Overview; 19.13.2 Products And Services; 19.14 iXCells Biotechnologies Inc.; 19.14.1 Company Overview; 19.14.2 Products And Services; 19.15 Cynata Therapeutics Limited; 19.15.1 Company Overview; 19.15.2 Products And Services
20 Competitive Benchmarking
21 Competitive Dashboard
22 Key Mergers And Acquisitions: 22.1 Shineco Acquired InfiniClone Ltd; 22.2 Axol Bioscience Ltd Acquired Phenocell SAS; 22.3 Century Therapeutics Acquired Clade Therapeutics; 22.4 QHP Capital Acquired Applied StemCell; 22.5 Vertex Pharmaceuticals Acquired ViaCyte; 22.6 Medipost Acquired OmniaBio
23 Recent Developments In The Induced Pluripotent Stem Cell (iPSC) Market: 23.1 Revolutionary Stem Cell Banking Brings Personalized Regenerative Care To The Masses; 23.2 Next-Generation NK Cell Therapy Platform Enhances Clinical Readiness; 23.3 Revolutionizing Cardiovascular Care With Personalized iPSC Solutions; 23.4 AI-Powered iPSC Foundry Improving Outcomes For Parkinson’s Patients
24 Opportunities And Strategies: 24.1 Global Induced Pluripotent Stem Cell (iPSC) Market In 2029 – Countries Offering Most New Opportunities; 24.2 Global Induced Pluripotent Stem Cell (iPSC) Market In 2029 – Segments Offering Most New Opportunities; 24.3 Global Induced Pluripotent Stem Cell (iPSC) Market In 2029 – Growth Strategies; 24.3.1 Market Trend Based Strategies; 24.3.2 Competitor Strategies
25 Induced Pluripotent Stem Cell (iPSC) Market, Conclusions And Recommendations: 25.1 Conclusions; 25.2 Recommendations; 25.2.1 Product; 25.2.2 Place; 25.2.3 Price; 25.2.4 Promotion; 25.2.5 People
26 Appendix: 26.1 Geographies Covered; 26.2 Market Data Sources; 26.3 Research Methodology; 26.4 Currencies; 26.5 The Business Research Company; 26.6 Copyright and Disclaimer

Search Inside Report

Pricing

Currency Rates

Single User Online Download $4,490
Site License Online Download $6,490
Global Site License Online Download $8,490

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now